Clinical trials
Learning clinical trials
Below are recruiting learning clinical trials, each written for real people, not researchers. We’re tracking 626 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06044337Enrolling by invitationPhase 3
Long-term safety study of litifilimab for skin lupus
This study is a long-term follow-up for people who already completed a 52-week study of the study drug litifilimab for active skin lupus. It will check the safety of continued treatment and see if it keeps helping symptoms.
Birmingham, AlabamaAges 18 years+ - NCT04941651Recruiting
Tele-nutrition program for weight and heart risk
This trial studies whether remote (phone/internet) nutrition coaching helps adults with obesity and/or higher risk for heart and blood vessel problems. It aims to improve weight and related health risks using regular telenutrition support.
ParisAges 18–75 - NCT05056597Recruiting
Brain and learning study in eating disorders and healthy adults
This study uses brain scans to understand how the brain processes rewards and learns in people with anorexia nervosa or bulimia nervosa, compared with healthy adults. It may help researchers find better ways to target learning and reward problems related to these eating disorders.
La Jolla, CaliforniaAges 18–39 - NCT05082181Recruiting
Phone group support for adults with epilepsy and depression
This study tests whether telephone-based group support helps adults with epilepsy who also have elevated depressive symptoms. Sessions are recorded, and you’ll join by phone in English or Spanish.
New York, New YorkAges 18–99 - NCT05106140Recruiting
Robots help measure arm learning after a new stroke
This study uses robotic devices to understand how your arm learns movement after a recent stroke. It may help researchers improve stroke rehabilitation by figuring out what kinds of practice work best.
Calgary, AlbertaAges 18 years+ - NCT05140889Recruiting
AI helps predict asthma severity in children
This trial studies an AI (computer) model that uses CT scan images plus health and blood/clinical information to predict how severe asthma is in children. It may help doctors better understand your child’s asthma severity and tailor care.
PaviaAges 6–17 - NCT05180786Recruiting
Brain-training therapy to improve arm movement after stroke
This study tests a learning-and-recovery approach meant to help people regain arm and hand control after a long-term stroke. It targets patients with specific movement and brain-connection patterns so the training can be safely done.
Chicago, IllinoisAges 18 years+ - NCT05188183Recruiting
Remote brain stimulation plus hand training for phantom limb pain
This trial tests whether remote brain stimulation (tDCS) combined with sensory (hand/limb) training can reduce phantom limb pain. It also uses computer prediction (“machine learning”) to estimate who is most likely to benefit.
Cambridge, MassachusettsAges 18 years+ - NCT05204186Recruiting
AI Tool to Predict Health Outcomes After Bladder Removal Surgery
This study tests an artificial intelligence tool designed to predict how patients will recover after bladder cancer surgery. The AI analyzes existing medical information to help doctors better understand which patients might face complications based on their other health conditions.
Amiens, PicardieAges 18 years+ - NCT05261139RecruitingPhase 3
Trial for PF-07321332 for children at risk from COVID-19
This trial studies whether PF-07321332 (with ritonavir) helps children under 18 who have COVID-19 at home but are at high risk of severe illness. It looks at whether starting treatment early can reduce progression to worse disease.
Phoenix, ArizonaAges birth–17 years - NCT05268861Recruiting
Understanding brain learning after stroke during arm training
This study looks at how thinking and brain processes affect learning to move your arm after a stroke. You may be asked to do arm tasks in a way that helps the researchers understand what helps or limits motor learning.
Laval, QuebecAges 40–75 - NCT05283382RecruitingEarly Phase 1
Cannabidiol trial for learning and anxiety
This early-phase study tests how cannabidiol (CBD) affects learning and anxiety. You may be able to join if you meet age and health requirements and have not used CBD or other cannabis recently.
Storrs, ConnecticutAges 18–50 - NCT05285059Recruiting
Study how children with epilepsy learn
This trial studies how children with epilepsy learn and process information compared with children without brain, mental health, or learning conditions. It may help researchers understand the learning needs of children living with epilepsy.
Bron, BronAges 8–14 - NCT05286892Recruiting
Diabetes education for people returning home from prison
This study offers diabetes learning through virtual (online) sessions for adults with diabetes who are transitioning back to community living after prison. It aims to help you better manage diabetes during reentry and improve day-to-day health.
Storrs, ConnecticutAges 18 years+ - NCT05296408Recruiting
Arm exoskeleton rehab for chronic stroke weakness
This trial tests a wearable arm exoskeleton that uses your muscle signals to help rehab a weak arm after stroke. It may help improve arm movement by pairing training with this device, but you must meet specific movement, skin, and scan-safety requirements.
Cleveland, OhioAges 18–89 - NCT05317390Recruiting
Tests an AI tool to diagnose isolated dystonia
This trial checks whether an AI (software) called DystoniaNet can accurately identify isolated dystonia using information from your evaluation, and compares its results to standard diagnosis. If you have focal, segmental, or generalized dystonia, this study may help improve faster and more accurate diagnosis in the future.
Boston, MassachusettsAges Any age - NCT05348876RecruitingPhase 4
Darolutamide plus standard hormone therapy for high-risk prostate cancer
This trial studies how safe darolutamide is and how well it works when added to standard hormone therapy for men with high-risk, non-metastatic prostate cancer that is no longer responding to hormone treatment. It may help slow prostate cancer growth and reduce prostate-specific antigen (PSA) rises in real-world care.
Vijayawada, Andhra PradeshAges 18 years+ - NCT05355701RecruitingPhase 1
Testing a new drug for advanced cancers with BRAF changes
This Phase 1 trial studies PF-07799933, a new medicine, in people whose advanced solid tumors have specific BRAF genetic changes. It may help if your cancer has continued to grow after standard treatments, and there may be specific options depending on your cancer type and past therapies.
Fayetteville, ArkansasAges 16 years+ - NCT05371405Recruiting
Using computer learning to improve care for atrial fibrillation patients
This study uses machine learning (computer pattern-finding) to better understand atrial fibrillation and guide care around the time of an ablation procedure. It may help refine how doctors treat certain AF patients based on their heart patterns.
Stanford, CaliforniaAges 22–80 - NCT05391061Recruiting
Cibinqo tablet study for moderate-to-severe atopic dermatitis
This study looks at Cibinqo (an oral medicine) in people with moderate-to-severe atopic dermatitis (eczema) who are already going to start it under their clinician’s standard care plan. It may help doctors learn about how the medicine works and fits into real-world treatment.
SeoulAges 12 years+ - NCT05394363Recruiting
Victoria children birth-cohort study with parent/guardian consent
This study follows children born in a specific 2-year window and their parents or guardians over time. It helps researchers understand how children and families change as they grow, which can guide future health supports in Victoria.
Parkville, VictoriaAges 1 day+ - NCT05396248Recruiting
Memory training study for older adults with mild memory problems
This trial tests an approach to improve learning and memory in people age 60+ with amnestic mild cognitive impairment (a specific type of early memory problem). It may help by supporting memory and learning skills, but it also has medication and health-history requirements.
Ann Arbor, MichiganAges 60 years+ - NCT05426135Recruiting
AI tool to assess cancer risk and guide care
This study tests an artificial intelligence (AI) system that uses your health information and medical images to better judge cancer risk and support diagnosis and treatment decisions. It may help doctors make more consistent assessments by combining clinical records, imaging, and other lab-style data.
Wuhan, HubeiAges 18–75 - NCT05452941Recruiting
Pneumonia vaccine study for hospitalized adults 65 and older
This study tests a pneumococcal vaccine designed for 20 types of bacteria in older adults who are hospitalized with suspected community-acquired pneumonia. It aims to see how the vaccine works in real-world care and whether it affects how pneumonia happens or progresses.
El Centro, CaliforniaAges 65 years+
Hear when a new Learning trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for learning?
- Yes. Clin2 currently lists 626 recruiting learning studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a learning trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a learning trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.